Sanders Morris Harris LLC Has $337,000 Position in Procter & Gamble Company (The) $PG

Sanders Morris Harris LLC lessened its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 70.1% in the second quarter, according to the company in its most recent filing with the SEC. The fund owned 2,295 shares of the company’s stock after selling 5,389 shares during the quarter. Sanders Morris Harris LLC’s holdings in Procter & Gamble were worth $337,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of PG. E Fund Management Hong Kong Co. Ltd. grew its position in shares of Procter & Gamble by 1,000.0% in the fourth quarter. E Fund Management Hong Kong Co. Ltd. now owns 165 shares of the company’s stock valued at $25,000 after purchasing an additional 150 shares during the last quarter. Park Square Financial Group LLC lifted its holdings in Procter & Gamble by 65.1% during the 4th quarter. Park Square Financial Group LLC now owns 180 shares of the company’s stock worth $26,000 after purchasing an additional 71 shares during the last quarter. Evolution Wealth Management Inc. boosted its stake in Procter & Gamble by 1,315.4% in the 4th quarter. Evolution Wealth Management Inc. now owns 184 shares of the company’s stock valued at $26,000 after purchasing an additional 171 shares during the period. Litman Gregory Wealth Management LLC acquired a new stake in shares of Procter & Gamble during the fourth quarter worth $26,000. Finally, Maseco LLP bought a new stake in shares of Procter & Gamble in the fourth quarter valued at about $28,000. 65.77% of the stock is owned by institutional investors.

Procter & Gamble Stock Performance

Shares of PG stock opened at $146.79 on Thursday. The firm has a market capitalization of $341.81 billion, a PE ratio of 22.17, a price-to-earnings-growth ratio of 4.55 and a beta of 0.39. The firm has a fifty day simple moving average of $147.80 and a two-hundred day simple moving average of $148.99. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $167.25. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.42.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.02. The business had revenue of $21.20 billion during the quarter, compared to the consensus estimate of $21.38 billion. Procter & Gamble had a return on equity of 31.25% and a net margin of 18.44%.The company’s quarterly revenue was up 1.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.48 EPS. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. Analysts forecast that Procter & Gamble Company will post 6.99 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, August 17th. Investors of record on Friday, July 24th will be issued a dividend of $1.0885 per share. The ex-dividend date is Friday, July 24th. This represents a $4.35 annualized dividend and a yield of 3.0%. Procter & Gamble’s payout ratio is 65.71%.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the company. Rothschild & Co Redburn lowered their price objective on Procter & Gamble from $157.00 to $155.00 and set a “neutral” rating on the stock in a research note on Monday, April 27th. Barclays upped their price objective on shares of Procter & Gamble from $146.00 to $152.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 21st. BMO Capital Markets boosted their target price on shares of Procter & Gamble from $169.00 to $170.00 and gave the company an “outperform” rating in a research report on Monday, June 29th. UBS Group increased their price target on shares of Procter & Gamble from $166.00 to $172.00 and gave the stock a “buy” rating in a research report on Monday, April 27th. Finally, HSBC restated a “hold” rating and set a $149.00 target price (down from $182.00) on shares of Procter & Gamble in a research note on Thursday, July 30th. Thirteen equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to data from MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and a consensus price target of $161.52.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: P&G agreed to acquire premium supplements company Thorne for $3.8 billion in cash. The transaction expands P&G’s health-care portfolio alongside brands such as Metamucil, Align and New Chapter, and gives the company greater exposure to premium wellness and younger consumers. The deal is expected to close later this year. P&G will acquire supplements brand Thorne
• Positive Sentiment: Management and Thorne’s owner described the acquisition as a way to build on Thorne’s science-backed brand and growth in wellness. Investors initially viewed the purchase as a strategic move to diversify P&G beyond traditional household and personal-care products. L Catterton announces sale of Thorne to P&G
• Neutral Sentiment: Trading activity in P&G call options increased, indicating heightened investor interest and potentially more bullish positioning around the acquisition. However, options activity alone does not establish a change in the company’s fundamentals. Traders purchase large volume of P&G call options
• Negative Sentiment: P&G’s latest quarterly results showed a mixed picture: earnings per share of $1.43 topped estimates by $0.02, but revenue of $21.2 billion missed the $21.38 billion consensus and rose only 1.5% year over year. The sales shortfall and ongoing input-cost pressure may be limiting enthusiasm for the stock. PG Q2 deep dive
• Negative Sentiment: The $3.8 billion cash purchase creates execution and valuation risk, including the challenge of integrating Thorne and generating sufficient growth from the premium supplement business. Investors may also be assessing the deal’s effect on P&G’s balance sheet and future returns.

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.